Matching slides 303,780
Current window 33,631-33,660
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

33,631-33,660 of 303,780

filter-aware
11
The slide uses a Gantt-style visualization to show the development status of multiple drug candidates.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
12
Tenaya Therapeutics | IPO Presentation Deck | 36 slidesTenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
13
The slide uses a split-screen layout to contrast the disease state (pathophysiology) with the therapeutic intervention (product concept).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product2 hits
14
Includes bar chart, line chart, and Kaplan-Meier survival curve.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · ProductLoop · Hypothesis Test2 hits
15
The slide uses bar charts with individual data points to demonstrate efficacy across three distinct physiological metrics.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product2 hits
16
The slide uses a three-column layout to present histological, VCN (vector copy number), and protein expression data.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product2 hits
17
The slide uses two distinct charts to show tissue specificity (bar chart) and functional efficacy (line chart with error bars).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product2 hits
19
The slide uses a two-column layout to contrast past achievements (Progress) with future goals (Next Steps).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Loop · Quick Win Big Bet2 hits
20
Tenaya Therapeutics | IPO Presentation Deck | 36 slidesTenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
21
Includes anatomical pathology image and molecular structure diagram of desmosomes.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
22
Slide shows three distinct charts: a line chart for RV area, a bar chart for ejection fraction, and a Kaplan-Meier survival curve.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
23
The slide compares WT, untreated PKP2-cKO (HBSS), and treated PKP2-cKO (AAV:mPKP2) using both a bar chart of arrhythmia scores and representative ECG traces.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
25
Tenaya Therapeutics | IPO Presentation Deck | 36 slidesTenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
26
Includes a biological mechanism diagram showing how HDAC6 inhibitors target multiple pathways leading to diastolic dysfunction and HFpEF.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
27
The slide outlines a proprietary R&D pipeline for identifying and validating drug targets using patient-derived cells and machine learning.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
28
The slide presents four bar charts comparing Control, Vehicle (disease model), and TYA-11631 (treatment) groups across four physiological metrics.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
29
The slide presents three distinct charts comparing Control, Vehicle-treated HFpEF, and TYA-11631-treated HFpEF groups.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
30
The slide presents three distinct sets of experimental results: glucose tolerance test, insulin sensitivity test, and inflammatory marker expression (Tgfb1, IL-6, IL-10).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
31
The slide uses a bar chart to show selectivity and a dose-response curve to show safety (thrombocytopenia risk).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
32
The slide uses a two-column layout to contrast past achievements (Progress) with future goals (Next Steps).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
34
Includes a biological mechanism diagram and a line chart showing Ejection Fraction improvement in murine models.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
35
The slide uses a three-column layout: Disease Overview, Product Concept, and In Vivo Data.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
36
The slide uses a timeline-based table for programs and an infographic for platforms.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 2 hits
36
The slide uses a process flow to explain the mechanism of action for the company's platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank 2 hits
14
The slide uses a stacked bar chart to show asset composition over time, with a callout box summarizing recent NNFGA performance and margin drivers.UBS | Results Presentation Deck | 27 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain2 hits
03
The chart displays 9 distinct brands with their respective studio counts.Xponential | IPO Presentation Deck | 44 slides · Xponential Fitness
Pitch deck Investment bank Beat · Humble OriginsLoop · Logic Chain2 hits
27
The background is a repeating pattern of various fitness brand logos.Xponential | IPO Presentation Deck | 44 slides · Xponential Fitness
Pitch deck Investment bank Beat · Ultimate Achievement2 hits
31
The background features a repeating pattern of brand logos.Xponential | IPO Presentation Deck | 44 slides · Xponential Fitness
Pitch deck Investment bank Beat · Ultimate Achievement2 hits
21
Zevia | IPO Presentation Deck | 46 slidesZevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Loop · Cost Of Inaction2 hits
22
The slide uses a comparison frame to highlight growth velocity.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Loop · Cost Of Inaction2 hits